Facebook Twitter LinkedIn Instagram Email Printer Google Plus

COVID-19

Insurance markets showed great resiliency during the past 18 months as employment numbers fluctuated. Looking ahead, multiple legislative, regulatory, and market moves may cause shifts in the payer enrollment mix.

Partner, Health and Life Sciences, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman
Associate, Oliver Wyman

How organizations are wresting with back-to-work plans in light of the Delta variant.

Managing Partner, Americas, Oliver Wyman

Featured in Dallas Morning News

It’s time to get women off the sidelines so the United States can meet its goal of getting at least one dose of vaccine to 70% of adults.

Chief Operating Officer, Oliver Wyman Forum; Partner, Chief Knowledge Officer, Oliver Wyman

The fight over healthcare reform shaped the past decade. How will a maturing Affordable Care Act shape the next?

Principal, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman
Senior Advisor, Oliver Wyman
Yan Zhou, Engagement Manager, Health and Life Sciences, Oliver Wyman

When redesigning their workplaces, leaders must reflect on employees' best interests, versus their own.

Global Head, Health Services, Oliver Wyman
Partner, Financial Services, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Digital, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Organizational Effectiveness & Transformation, Oliver Wyman

Insights in your inbox

Subscribe

Plus, Why We Should Still Be Thinking About Cumulative Population Immunity

Three takeaways from our analysis on possible Herd Immunity Threshold and how to reach it together.

Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

With the pandemic accelerating transformation, AMC strategies must reimagine their operations to deliver new value.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

Considerations for Consumers, Providers, and Payers

The concept of “healthcare delivery” is dramatically shifting and opportunities for stakeholders abound.

VP of Client Delivery, Quil

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

Why Organizational Structures Will Experience an Overhaul

Flexible staffing models, broad leadership skill sets, non-traditional collaboration, and more will help organizations thrive post-pandemic.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Organizational Effectiveness, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman

Insights in your inbox

Subscribe